HLA-B and toxic epidermal necrolysis: It is known that in certain Asian populations, HLA-B gene status is a critical factor for safe prescribing of CBZ and its analogs due to the prevalence of the HLA-B∗15:02 allele and its association with risk of severe adverse events including SJS and TEN.